DEA moves to fight shortages of medicines needed for Covid-19 patients
The Drug Enforcement Administration is taking steps to permit increased production and importation of various…
Category: Biotech
Wealthy nations urged to embrace WTO deal and import meds made under compulsory licenses
In the latest effort to widen access to Covid-19 medical products, three dozen countries are…
New research examines wastewater to detect community spread of Covid-19
A series of crucial setbacks in Covid-19 testing has made it difficult to keep up…
STAT Plus: Lilly lowers most insulin costs to $35 a month in response to Covid-19
In response to the financial hit many people are taking due to the coronavirus pandemic,…
Opinion: While social distancing, do your other patriotic duty: have The Conversation about serious illness care
At no time since World War II has there been a clarion call for the…
Coronavirus-related layoffs hit health tech startups
With the economy in freefall amid the coronavirus pandemic, some health tech startups have started…
STAT Plus: Pharmalittle: India to allow limited exports of malaria drug; some Trump allies profit if hydroxychloroquine is approved
Good morning, everyone, and how are you today? As the saying goes, stay on the…
STAT Plus: Biotech in the time of coronavirus: Pondering the future of ‘JPM Week’
I logged into a Zoom meeting wearing a fuzzy robe. Greetings and welcome to another…
Opinion: Misinformation about an outbreak like Covid-19 is important public health data
One of us (L.H.-D.) heard the first official news of the coronavirus outbreak in China…
Opinion: Using social distancing to test if technology can solve the loneliness epidemic
As the coronavirus spreads exponentially across the United States, widespread social distancing is thought to…
Former Novartis exec wants to repurpose generic drugs to fight Covid-19
As Covid-19 sweeps the globe, a growing number of efforts are underway to quickly research…
A $30 billion gamble: Pandemic expert calls for making Covid-19 vaccines before we know they work
There’s a one-word exit strategy for the devastating Covid-19 pandemic, which is crippling economies around…
The U.S. gets a D- in the coronavirus fight. That stands for ‘disorganization,’ and it’s fixable
NEW YORK — Leora Horwitz has seen other disasters. Now the director of the Center…
‘We’re flying blind’: African Americans may be bearing the brunt of Covid-19, but access to data are limited
Stark statistics are coming to light only now and only in piecemeal fashion showing that…
Fact-checking Trump’s claims about hydroxychloroquine, the antimalarial drug he’s touting as a coronavirus treatment
WASHINGTON — President Trump can’t seem to stop talking about hydroxychloroquine. There is currently no…
WHO director-general endorses a voluntary intellectual property pool to develop Covid-19 products
Amid the race to find a salve for Covid-19, the World Health Organization director-general has…
Data for Gilead’s potential coronavirus therapy are coming soon. Here’s what you need to know
This month, the world should get the first results from a clinical trial testing the…
Martin Shkreli is trying to use the coronavirus pandemic to get out of prison
Martin Shkreli, currently serving a seven-year sentence for securities fraud, has a pitch to authorities:…
STAT Plus: Alnylam and Dicerna, onetime rivals, announce a ceasefire
Rival biotechs Alnylam and Dicerna are announcing a ceasefire. The two companies, which are both…
STAT Plus: Pharmalittle: States try to prevent hoarding of drug used for Covid-19; is BARDA ready for the coronavirus?
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Immunomedics halts late-stage clinical trial, confirming drug benefit for aggressive type of breast cancer
Immunomedics is stopping a Phase 3 clinical trial due to “compelling evidence of efficacy” demonstrated…
GlaxoSmithKline and Vir aim to take on Covid-19 with antibodies and CRISPR
The drug giant GlaxoSmithKline said Monday it will collaborate with Vir Biotechnology on experimental treatments…
Opinion: Predicting immunotherapy success: We’ve mastered the foothills but the summit lies ahead
The Nobel Prize-winning discovery of immune checkpoint inhibitors has changed how cancer is treated. These…
The Covid-19 pandemic forces a new way of thinking for Quil, Comcast’s health tech startup
When telecom giant Comcast and health insurer Independence Blue Cross teamed up to found Quil…
Opinion: The ‘certified recovered’ from Covid-19 could lead the economic recovery
Re-opening a nightclub in New York seems crazy at this point, as that’s just the…
Discovery of racial bias in health care AI wins STAT Madness ‘Editors’ Pick’
Although “garbage in, garbage out” has been a software truism for more than half a…
MIT’s Koch Institute wins STAT Madness with technology to see tiny ovarian tumors
Carbon nanotubes rule. In this year’s STAT Madness, a bracket-style competition to honor the best…
.jpg)
This tiny federal agency was built to respond to a crisis like coronavirus. Now that it’s here, is BARDA ready?
WASHINGTON — It seems like an agency tailor-made for a crisis like the coronavirus pandemic….
STAT Plus: Digital health startups scored a critical cash infusion at the start of this year
As much of the world prepares for the possibility of a coronavirus-driven recession, a new…
Gilead ramps up production of experimental Covid-19 treatment amid criticism over access
In response to intensifying demand, Gilead Sciences has been ramping up production of its experimental remdesivir…
Opinion: A deficit of more than 250,000 public health workers is no way to fight Covid-19
What happens when a nation systematically cuts or underfunds its public health workforce? We are…
CDC launches studies to get more precise count of undetected Covid-19 cases
The Centers for Disease Control and Prevention has begun preliminary studies to try to determine…
Opinion: I’ve been cared for by dozens of clinicians in nearly 20 years. I’m in awe of their work on Covid-19
To health care workers on the front lines: thank you. As a rare disease patient…
An interview with the CDC director on coronavirus, masks, and an agency gone quiet
Robert Redfield, director of the Centers for Disease Control and Prevention, describes the coronavirus pandemic…
White House urges Americans to wear cloth face coverings in public in bid to slow coronavirus spread
WASHINGTON — President Trump on Friday announced new federal guidance that encourages Americans to use…
.jpg)
STAT Plus: Boston Scientific cutting hours and pay as revenue drops
Boston Scientific said Thursday that it’s cutting wages for many of its roughly 36,000 global…
STAT Plus: Pharmalittle: Sanofi poised to supply millions of doses of malaria drug; Roche unit apologizes for ‘Wuhan’ virus label
And so, another working week will soon draw to a close. Not a moment too…
Opinion: I got Covid-19 and got lucky. The emotional impact hurt more
I tested positive for Covid-19 not long ago. It wasn’t a worried-well test, or even…
A nurse’s coronavirus routine: Recording videos she hopes her family will never need to watch
The words are familiar at first, a bedtime trope so dependable that it’s hard to…
Opinion: The Covid-19 crisis too few are talking about: health care workers’ mental health
In the midst of this global pandemic, people are talking about the urgent and critical…
STAT Plus: ‘Science is very much a part of culture’: Siddhartha Mukherjee dives into the history of genetics in a new Ken Burns film
One of the world’s most well-known oncologists and one of the world’s most well-known documentary…
Americans are underestimating how long coronavirus disruptions will last, health experts say
Public health experts are increasingly worried that Americans are underestimating how long the coronavirus pandemic…
Listen: Pandemic exit strategies, how the outbreak affects patients, and Ken Burns takes on DNA
When will things go back to normal? What if a pandemic strikes when you’re already…
White House expected to recommend all Americans wear cloth masks to prevent coronavirus spread
WASHINGTON — The White House is expected to announce a new policy, based on guidance…
STAT Plus: Large employers could have saved money if more biosimilars had been prescribed
If some of the largest U.S. employers had used biosimilar versions of a pair of…
Opinion: Every American should wear a face mask to defeat Covid-19
To mask, or not to mask? That is the question. And it needs an answer…
STAT Plus: The latest failure in Alzheimer’s casts doubt on Biogen’s ostensible success
The prevailing theory of how to treat Alzheimer’s disease endured its 1,001st cut on Thursday,…
STAT Plus: Pharmalittle: Novartis scraps generic sale to Aurobindo; another small study suggests old malaria drug works
Rise and shine, everyone, another busy day is on the way. How could it be…
STAT Plus: Big biotech venture funds raise billions despite coronavirus fears
The economy is grinding to a near-halt because of Covid-19. In the biotechnology sector, which…
Opinion: Invoking Bayh-Dole may be needed to get affordable Covid-19 treatments
As the Covid-19 pandemic strains the capacity of the U.S. health care system, attention is…